HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 5 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,599,280 | +19.7% | 120,400 | +13.1% | 0.00% | 0.0% |
Q2 2023 | $3,841,455 | -28.0% | 106,500 | -23.8% | 0.00% | -50.0% |
Q1 2023 | $5,338,962 | +15.1% | 139,800 | +71.5% | 0.00% | 0.0% |
Q4 2022 | $4,637,350 | +21.9% | 81,500 | -15.3% | 0.00% | 0.0% |
Q3 2022 | $3,804,000 | -54.9% | 96,200 | -49.8% | 0.00% | -50.0% |
Q2 2022 | $8,439,000 | – | 191,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 47,000 | $1,695,290 | 0.01% |
SIMPLEX TRADING, LLC | 66,100 | $2,384 | 0.00% |
JANE STREET GROUP, LLC | 106,500 | $3,841,455 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |